Covovax vaccine to get booster dose approval in 10-15 days: SII CEO Adar Poonawalla

Adar Poonawalla, Chief Executive Officer of Serum Institute of India, has stated that their Covovax vaccine would be approved as a booster dosage against Covid-19 within the next 10 to 15 days. According to Poonawalla, the vaccination is particularly effective against the Omicron strain of coronavirus.

Speaking to reporters on the sidelines of an event at the Bharati Vidyapeeth University here on Sunday, the SII CEO said: “Central Government has a lot of stock of Covisheild and also Covovax vaccine will get approval as a booster in the next 10 to 15 days.” On being asked about the availability of the Covisheild vaccine, and its lack of supply to the state and district, Adar Poonawalla said, “The central government has a lot of stock of Covisheild they can give it to the state, as of now production of Covisheild is at a halt at SII, we can start it if needed but the Covovax vaccine will get approval as a booster in the next 10 to 15 days, it works well against the Omicron variant of coronavirus.”

He added, “During Covid-19, everyone was looking at India, not just in terms of healthcare but because the country managed to take care of a huge population and also helped 70 to 80 nations, This was all possible because of the leadership of our central government and state governments, healthcare workers, manufacturers, all of whom worked together with one common goal.”

Poonawalla was also honoured on the occasion of Dr. Patangrao Kadam’s birth anniversary in Maharashtra by NCP head Sharad Pawar and Deputy Chief Minister Devendra Fadnavis.